TTC19 and neoplasm: In addition, we also show that other complex III components are upregulated in the late stages of human high grade serous ovarian cancers (HGSOCs), in which TRAP1 is downmodulated, and identify the assembly factor TTC19 as a novel biomarker of potential clinical interest in this tumor type.